Wilmington PharmaTech targets larger commercial API volumes with $50m Delaware expansion
Wilmington PharmaTech is investing $50 million to expand Delaware API capacity. Read why this could reshape U.S. small-molecule supply.
Wilmington PharmaTech is investing $50 million to expand Delaware API capacity. Read why this could reshape U.S. small-molecule supply.